RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

Roche RSS Channel

Display # 
Title Published Date
Roche to restructure its manufacturing network for small molecules 18 November 2015
Roche delivers strong sales growth in the first nine months of 2015 26 October 2015
Roche's ocrelizumab first investigational medicine to show positive pivotal study results in both relapsing and primary progressive forms of multiple sclerosis 09 October 2015
New Roche Esbriet data show clinical benefits of continued and long-term treatment in patients with idiopathic pulmonary fibrosis (IPF) 01 October 2015
For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices 14 September 2015
"Roche Continents" fosters innovation in science and art 11 August 2015
Roche employees unite to raise funds for children in need 16 June 2015
Roche reports strong sales growth in the first quarter of 2015 23 April 2015
Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics 11 February 2015
Roche acquires Trophos to expand portfolio in neuromuscular disease with high medical need 20 January 2015
Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology 12 January 2015
Roche to invest 450 million Swiss Francs in new diagnostic manufacturing facility in China 05 November 2014
Roche delivers solid sales growth for the first nine months of 2014 19 October 2014
Roche again ranked most sustainable healthcare company in the Dow Jones Sustainability Indices 14 September 2014
Roche and InterMune reach definitive merger agreement 25 August 2014
FDA approves Roche's Avastin plus chemotherapy for treatment of advanced cervical cancer 18 August 2014
Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines 05 August 2014
Roche announces definitive agreement to acquire Seragon Pharmaceuticals 02 July 2014
Roche Children's Walk 2014 19 June 2014
Roche with good start in 2014 15 April 2014

Digest World Pharma Newsletter

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]